Role of Functional Imaging in Head and Neck Squamous Cell Carcinoma: Fluorodeoxyglucose Positron Emission Tomography and Beyond

被引：9
|
作者：
Porceddu, Sandro V. [1 ,2 ]
Burmeister, Bryan H. [1 ,2 ]
Hicks, Rodney J. [3 ]
机构：
[1] Princess Alexandra Hosp, Div Canc Serv, Brisbane, Qld 4102, Australia
[2] Univ Queensland, Sch Med, Brisbane, Qld 4102, Australia
[3] Peter MacCallum Canc Ctr, Ctr Mol Imaging, Melbourne, Vic 8006, Australia
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2008年 / 22卷 / 06期
关键词：
PET; Head and neck; Squamous cell carcinoma; Radiotherapy; Chemotherapy;
D O I：
10.1016/j.hoc.2008.08.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Positron emission tomography (PET) has emerged as an integral diagnostic tool in the management of head and neck squamous cell carcinoma (HNSCC). This article reviews the usefulness and ongoing dilemmas of fluorine-18 fluorodeoxyglucose (18-F FDG) PET and FDG PET/CT in HNSCC. In addition, it examines the potential role of novel markers and biologic characterization of disease, which in the future may assist in targeted therapeutic strategies.
引用
收藏
页码：1221 / +
页数：20
相关论文
共 50 条
  • [11] Genetic alterations associated with 18F-fluorodeoxyglucose positron emission tomography/computed tomography in head and neck squamous cell carcinoma
    Han, Sangwon
    Oh, Jungsu S.
    Lee, Hyo Sang
    Kim, Jae Seung
    TRANSLATIONAL ONCOLOGY, 2021, 14 (02):
  • [12] Fluorodeoxyglucose-positron emission tomography/computed tomography imaging of squamous cell carcinoma arising in a meningomyeloceled
    Erhamamci, Seval
    Reyhan, Mehmet
    Bal, Nebil
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2016, 31 (02): : 411 - 412
  • [13] Diagnostic and prognostic value of [18F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma
    Wong, RJ
    Lin, DT
    Schöder, H
    Patel, SG
    Gonen, M
    Wolden, S
    Pfister, DG
    Shah, JP
    Larson, SM
    Kraus, DH
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (20) : 4199 - 4208
  • [14] Evaluation of recurrent squamous cell carcinoma of the head and neck with FDG positron emission tomography
    Li, PY
    Zhuang, HM
    Mozley, PD
    Denittis, A
    Yeh, D
    Machtay, M
    Smith, R
    Alavi, A
    CLINICAL NUCLEAR MEDICINE, 2001, 26 (02) : 131 - 135
  • [15] Effects of positron emission tomography on patients with advanced squamous cell carcinoma of the head and neck
    Hsieh, H. -Y.
    Lin, J. -C.
    Lin, P. -J.
    Liu, Y. -C.
    ANNALS OF ONCOLOGY, 2015, 26 : 97 - 97
  • [16] The Utility of Interim Positron Emission Tomography Imaging to Inform Adaptive Radiotherapy for Head and Neck Squamous Cell Carcinoma
    Rosen, Benjamin S.
    Vaishampayan, Neil
    Cao, Yue
    Mierzwa, Michelle L.
    CANCER JOURNAL, 2023, 29 (04): : 243 - 247
  • [17] Combined [18F]fluorodeoxyglucose positron emission tomography and computed tomography for detecting contralateral neck metastases in patients with head and neck squamous cell carcinoma
    Kim, Sang Yoon
    Kim, Jae Seung
    Doo, Hyungtak
    Lee, Hana
    Lee, Jeong Hyun
    Cho, Kyung-Ja
    Choi, Seung-Ho
    Nama, Soon Yuhl
    Roh, Jong-Lyel
    ORAL ONCOLOGY, 2011, 47 (05) : 376 - 380
  • [18] Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck
    Fischbein, NJ
    Aassar, OS
    Caputo, GR
    Kaplan, MJ
    Singer, MI
    Price, DC
    Dillon, WP
    Hawkins, RA
    AMERICAN JOURNAL OF NEURORADIOLOGY, 1998, 19 (07) : 1189 - 1196
  • [19] [18F]Fluorodeoxyglucose Positron Emission Tomography in the Initial Staging of Squamous Cell Carcinoma of the Head and Neck: Promise, Evidence, and Reality
    de Souza, Jonas A.
    Cohen, Ezra E. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (28) : E516 - E516
  • [20] Positron emission tomography for basal cell carcinoma of the head and neck
    Fosko, SW
    Hu, WM
    Cook, TF
    Lowe, VJ
    ARCHIVES OF DERMATOLOGY, 2003, 139 (09) : 1141 - 1146
12345